Merck (MRK) Change in Acquisitions & Divestments (2009 - 2026)

Merck (MRK) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $46.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments rose 557.14% year-over-year to $46.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 113.26% YoY), while the FY2025 annual figure was $1.7 billion, up 345.09% from the prior year.
• Change in Acquisitions & Divestments eased to $46.0 million in Q4 2025 per MRK's latest filing, from $575.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $704.0 million in Q3 2023 and bottomed at -$709.0 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $195.4 million across 5 years, with a median of $260.0 million in 2024.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments slumped 154.14% — and 2023, when it jumped 49900.0%.
• Merck's Change in Acquisitions & Divestments stood at -$497.0 million in 2021, then tumbled by 42.66% to -$709.0 million in 2022, then jumped by 123.84% to $169.0 million in 2023, then tumbled by 95.86% to $7.0 million in 2024, then soared by 557.14% to $46.0 million in 2025.
• Business Quant data shows MRK's Change in Acquisitions & Divestments at $46.0 million in Q4 2025, $575.0 million in Q3 2025, and $601.0 million in Q2 2025.